AAAAAA

   
Results: 1-10 |
Results: 10
Additive IOP-reducing effect of latanoprost in patients insufficiently controlled on timolol
Authors: Bron, AM Denis, P Nordmann, JP Rouland, JF Sellem, E Johansson, M
Citation: Am. Bron et al., Additive IOP-reducing effect of latanoprost in patients insufficiently controlled on timolol, ACT OPHTH S, 79(3), 2001, pp. 289-293
An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients
Authors: Rouland, JF Peigne, G Sellem, E Renard, JP Williamson, W Filippi, JM Hamard, P Abellan, P Chagnon, A Malet, F Haye, I
Citation: Jf. Rouland et al., An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients, J FR OPHTAL, 24(3), 2001, pp. 233-243
High prevalence of sleep-disordered breathing in patients with primary open-angle glaucoma
Authors: Onen, SH Mouriaux, F Berramdane, L Dascotte, JC Kulik, JF Rouland, JF
Citation: Sh. Onen et al., High prevalence of sleep-disordered breathing in patients with primary open-angle glaucoma, ACT OPHTH S, 78(6), 2000, pp. 638-641
Relevance of quality of life and treatment compliance measurement in patients with chronic open-angle glaucoma
Authors: Baudouin, C Bechetoille, A Bron, A Denis, P Nordmann, JP Renard, JP Rouland, JF Sellem, E Rigeade, MC Arnould, B
Citation: C. Baudouin et al., Relevance of quality of life and treatment compliance measurement in patients with chronic open-angle glaucoma, J FR OPHTAL, 23(10), 2000, pp. 1057-1064
Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists
Authors: Nordmann, JP Soderstrom, M Rouland, JF Malecaze, F
Citation: Jp. Nordmann et al., Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists, BR J OPHTH, 84(2), 2000, pp. 181-185
Survival after malignant tumors of the orbit and periorbit treated by exenteration
Authors: Mouriaux, F Martinot, V Pellerin, P Patenotre, P Rouland, JF Constantinides, G
Citation: F. Mouriaux et al., Survival after malignant tumors of the orbit and periorbit treated by exenteration, ACT OPHTH S, 77(3), 1999, pp. 326-330
A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF(2 alpha) metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension
Authors: Nordmann, JP Rouland, JF Mertz, BP
Citation: Jp. Nordmann et al., A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF(2 alpha) metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension, CURR MED R, 15(2), 1999, pp. 87-93
Is the functional prognosis of congenital glaucoma so unfavorable?
Authors: Rouland, JF
Citation: Jf. Rouland, Is the functional prognosis of congenital glaucoma so unfavorable?, J FR OPHTAL, 22(5), 1999, pp. 591-592
Congenital pigmentary epithelial hyperplasia
Authors: Rouland, JF
Citation: Jf. Rouland, Congenital pigmentary epithelial hyperplasia, J FR OPHTAL, 22(5), 1999, pp. 593-593
Pitfalls in exploring a papillary excavation
Authors: Rouland, JF
Citation: Jf. Rouland, Pitfalls in exploring a papillary excavation, J FR OPHTAL, 22(1), 1999, pp. 94-98
Risultati: 1-10 |